ArticleiScience2025

CRISPR/Cas9-mediated SHP-1-knockout T cells combined with simvastatin enhances anti-tumor activity in humanized-PDX HCC model.

Huaping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.